Autologous cytokine-induced killer cells in the treatment of multiple myeloma concomitant with lung cancer and paraneoplastic dermatoses

Internal Medicine

Volumn 49, Issue 21, 2010, Pages 2341-2346

  Lin, Jie ^a   Zhu, Hongli ^a   Lu, Xuechun ^a   Yang, Bo ^a   Han, Weidong ^a   Dai, Hanren ^a   Wang, Yao ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Cytokine induced killer cells; Lung cancer; Multiple myeloma; Paraneoplastic dermatoses

Indexed keywords

CALCIPOTRIOL; CARCINOEMBRYONIC ANTIGEN; CD56 ANTIGEN; DNA TOPOISOMERASE (ATP HYDROLYSING); EPIDERMAL GROWTH FACTOR RECEPTOR 2; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; KI 67 ANTIGEN; MOMETASONE FUROATE; RECOMBINANT INTERLEUKIN 2; TRIAMCINOLONE ACETONIDE; VASCULOTROPIN;

AGED; ARTICLE; BONE MARROW EXAMINATION; CANCER IMMUNOTHERAPY; CASE REPORT; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ISOLATION; CELL SURVIVAL; COCULTURE; COMPUTER ASSISTED TOMOGRAPHY; CYTOKINE INDUCED KILLER CELL; DRUG FEVER; ERYTHEMA; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; IMMUNOHISTOCHEMISTRY; LOBECTOMY; LUNG CANCER; LUNG TUMOR; LYMPH NODE DISSECTION; MALAISE; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC SYNDROME; PLASMA CELL; RASH; SKIN DISEASE; SKIN EXFOLIATION; SQUAMOUS CELL CARCINOMA;

AGED; CELLS, CULTURED; CYTOKINE-INDUCED KILLER CELLS; HAND DERMATOSES; HUMANS; IMMUNOTHERAPY, ADOPTIVE; LUNG NEOPLASMS; MALE; MULTIPLE MYELOMA; PARANEOPLASTIC SYNDROMES; TRANSPLANTATION, AUTOLOGOUS;

EID: 78249265619     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.49.3996     Document Type: Article

References (21)

1. Shi YJ, Yu JR, Cen XN, Zhu P, Ma MX. Large-capacity expanded cytokine-induced killer cells and its cytotoxic activity. J Biomed Eng 18: 94-96, 2001.
2. Schmidt-Wolf IG, Lefterova P, Mehta BA, et al. Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells. Exp Hematol 21: 1673-1679, 1993.
3. Lu PH, Negrin RS. A novel population of expanded human CD3+ CD56+cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency. J Immunol 153: 1687-1696, 1994.
4. Hoyle C, Bangs CD, Chang P, Kamel O, Mehta B, Negrin RS. Expansion of Philadelphia chromosome-negative CD3(+)CD56(+) cytotoxic cells from chronic myeloid leukemia patients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice. Blood 92: 3318-3327, 1998.
5. Mehta BA, Schmidt-Wolf IG, Weissman IL, Negrin RS. Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+CD56+killer cells. Blood 86: 3493-3499, 1995.
6. Schmidt-Wolf IGH, Lefterova P, Johnston V, et al. Sensitivity of multidrug-resistant tumor cell lines to immunologic effector cells. Cell Immunol 169: 85-90, 1996.
7. Jiang H, Liu KY, Tong CR, Jiang B, Lu DP. The efficacy of chemotherapy in combination with auto-cytokine-induced killer cells in acute leukemia. Zhonghua Nei Ke Za Zhi 44: 198-201, 2005 (in Chinese).
8. Linn YC, Hui KM. Cytokine-induced killer cells: NK-like T cells with cytotolytic specificity against leukemia. Leuk Lymphoma 44: 1457-1462, 2003.
9. Hui D, Qiang L, Jian W, Ti Z, Da-Lu K. A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma. Dig Liver Dis 41: 36-41, 2009.
10. Weng DS, Zhou J, Zhou QM, et al. Minimally invasive treatment combined with cytokine-induced killer cells therapy lower the short-term recurrence rates of hepatocellular carcinomas. J Immunother 31: 63-71, 2008.
11. Kim HM, Lim J, Park SK, et al. Antitumor activity of cytokineinduced killer cells against human lung cancer. Int Immunopharmacol 7: 1802-1807, 2007.
12. Jiang J, Xu N, Wu C, et al. Treatment of advanced gastric cancer by chemotherapy combined with autologous cytokine-induced killer cells. Anticancer Res 26: 2237-2242, 2006.
13. Pang J, Gao X, Liu X, et al. Enhanced antitumor effects by the coculture of allotumor RNA-pulsed dendritic cells with autologous cytokine-induced killer cells on hormone-refractory prostate cancer.Cancer Invest 18: 1-8, 2007.
14. Kornacker M, Moldenhauer G, Herbst M, et al. Cytokine-induced killer cells against autologous CLL: direct cytotoxic effects and induction of immune accessory molecules by interferon-gamma. Int J Cancer 119: 1377-1382, 2006.
15. Leemhuis T, Wells S, Scheffold C, Edinger M, Negrin RS. A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma. Biol Blood Marrow Transplant 11: 181-187, 2005.
16. Märten A, Renoth S, von Lilienfeld-Toal M, et al. Enhanced lytic activity of cytokine-induced killer cells against multiple myeloma cells after co-culture with idiotype-pulsed dendritic cells. Haematologica 86: 1029-1037, 2001.
17. Shi Y, Yu J, Cen X, Zhu P, Ma M. Large-capacity and expanded cytokine-induced killer cells and its cytotoxic activity. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 18: 94-96, 2001.
18. Bian J, Tan Y, Fang YQ, et al. Effects of CIK on the Lymphocytes Immunophenotype in Patients with Lung Cancer. Maternal and Child Health Care of China 22: 2979-2981, 2005 (in Chinese, Abstract in English).
19. Wu C, Jiang J, Shi L, Xu N. Prospective study of chemotherapy in combination with cytokine-induced killer cells in patients suffering from advanced non-small cell lung cancer. Anticancer Res 28: 3997-4002, 2008.
20. Sun JF, Lou YR, Mu QT, et al. Immunophenotype analysis of 32 patients with mutiple myeloma. Modern Practical Medicine 1: 17-19, 2005 (in Chinese, Abstract in English).
21. Perri RT, Oken MM, Kay NE. Enhanced T cell suppression is directed toward sensitive circulating B cells in multiple myeloma. J Lab Clin Med 99: 512-519, 1982.